Digitoxin inhibits ICC cell properties via the NF‑κB/ST6GAL1 signaling pathway
Oncology Reports · 2024
DOI: 10.3892/or.2024.8762 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Yueping Zhan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory Medicine Center, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chin…. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Cell Proliferation, Cholangiocarcinoma, Digitoxin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory Medicine Center, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, P.R. China.
Zitieren
APA
Zhan, Y., Wang, R., Huang, C., Xu, X., Xiao, X., Wu, L., Wei, J., Long, T., & Gao, C. (2024). Digitoxin inhibits ICC cell properties via the NF‑κB/ST6GAL1 signaling pathway. Oncology Reports. https://doi.org/10.3892/or.2024.8762
Vancouver
Zhan Y, Wang R, Huang C, Xu X, Xiao X, Wu L, et al. Digitoxin inhibits ICC cell properties via the NF‑κB/ST6GAL1 signaling pathway. Oncology Reports. 2024. doi:10.3892/or.2024.8762
BibTeX
@article{Zhan2024,
author = {Zhan, Yueping and Wang, Rong and Huang, Chenjun and Xu, Xuewen and Xiao, Xiao and Wu, Linlin and Wei, Jiao and Long, Tian and Gao, Chunfang},
title = {Digitoxin inhibits ICC cell properties via the NF‑κB/ST6GAL1 signaling pathway},
journal = {Oncology Reports},
year = {2024},
doi = {10.3892/or.2024.8762}
}
EUVIMED